Highlighted Publications
Comparative Pathology of Animal Models for Influenza A Virus Infection. Kirk, N. M., Liang, Y. & Ly, H., Jan 2024, In: Pathogens. 13, 1, 35.
Pathogenesis and virulence of coronavirus disease: Comparative pathology of animal models for COVID-19. Kirk, N. M., Liang, Y. & Ly, H., 2024, In: Virulence. 15, 1, 2316438.
Assessment of Immune Responses to a Trivalent Pichinde Virus-Vectored Vaccine Expressing Hemagglutinin Genes from Three Co-Circulating Influenza A Virus Subtypes in Pigs. Kumari, S., Chaudhari, J., Huang, Q., Gauger, P., De Almeida, M. N., Ly, H., Liang, Y. & Vu, H. L. X., Dec 2023, In: Vaccines. 11, 12, 1806.
Recombinant Pichinde viral vector expressing tuberculosis antigens elicits strong T cell responses and protection in mice. Kirk, N. M., Huang, Q., Vrba, S., Rahman, M., Block, A. M., Murphy, H. L., White, D., Namugenyi, S. B., Ly, H., Tischler, A. D. & Liang, Y., Feb 8 2023, In: Frontiers in immunology. 14, 1127515.
Evaluating the Biological Role of Lassa Viral Z Protein-Mediated RIG-I Inhibition Using a Replication-Competent Trisegmented Pichinde Virus System in an Inducible RIG-IN Expression Cell Line. Di, D., Huang, Q., Ly, H. & Liang, Y., Aug 2022, In: Journal of virology. 96, 16
Hearing loss in outbred Hartley guinea pigs experimentally infected with Pichinde virus as a surrogate model of human mammarenaviral hemorrhagic fevers. Brisse, M. E., Fernández-Alarcón, C., Huang, Q., Kirk, N. M., Schleiss, M. R., Liang, Y. & Ly, H., 2022, In: Virulence. 13, 1, p. 1049-1061 13 p.
Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs. Kumari, S., Chaudhari, J., Huang, Q., Gauger, P., De Almeida, M. N., Liang, Y., Ly, H. & Vu, H. L. X., Sep 2022, In: Vaccines. 10, 9, 1400.
Influenza A virus activates cellular Tropomyosin receptor kinase A (TrkA) signaling to promote viral replication and lung inflammation. Verma, V., Dileepan, M., Huang, Q., Phan, T., Hu, W. S., Ly, H. & Liang, Y., Sep 2022, In: PLoS pathogens. 18, 9, e1010874.
SARS-CoV-2 in companion animals: Do levels of SARS-CoV-2 seroconversion in pets correlate with those of pet’s owners and with protection against subsequent SARS-CoV-2 infection? Murphy, H. L., Sanchez, S., Ahmed, S., Rahman, M. M., Di, D., Dileepan, M., Heinrich, D., Liang, Y. & Ly, H., 2022, In: Virulence. 13, 1, p. 1216-1220